e-learning
resources
Virtual 2020
Pre-Congress Content
Novel insights into exercise training
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Who is able to adhere to exercise during non-surgical treatment for lung cancer?
L. Denehy (Melbourne (VIC), Australia), C. Granger (Melbourne (VIC), Australia), L. Edbrooke (Melbourne (VIC), Australia)
Source:
Virtual Congress 2020 – Novel insights into exercise training
Session:
Novel insights into exercise training
Session type:
E-poster session
Number:
3237
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Denehy (Melbourne (VIC), Australia), C. Granger (Melbourne (VIC), Australia), L. Edbrooke (Melbourne (VIC), Australia). Who is able to adhere to exercise during non-surgical treatment for lung cancer?. 3237
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Why can initial treatment of localised lung cancer fail?
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007
Who should treat lung cancer patients and where should they be treated?
Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients
Year: 2009
Some characteristics of patients with lung cancer elected for palliative treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 432s
Year: 2003
The impact of thoracic radiation therapy in lung function and exercise capacity in patients with breast cancer
Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise
Year: 2010
Are biphosphonates efficient in the adjuvant treatment of lung cancer?
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006
Poor performance status patient in advanced lung cancer: to treat or not to treat?
Source: Annual Congress 2008 - MP13 - Poor performance status patient in advanced lung cancer: to treat or not to treat?
Year: 2008
Can shuttle walk predict surgical outcome in lung cancer surgery?
Source: Eur Respir J 2004; 24: Suppl. 48, 74s
Year: 2004
Patient experiences of home-based rehabilitation during treatment for inoperable lung cancer.
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018
Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018
Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016
Lung function estimation in patients with lung cancer qualified for surgical treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006
The effect of a prehabilitation program on cardiorespiratory capacity following neoadjuvant treatment prior to surgery for locally advanced esophagogastric cancer
Source: International Congress 2017 – Best abstracts in the management of chronic respiratory diseases
Year: 2017
An educational intervention for lung cancer patients treated with chemotherapy: a first evaluation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007
Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables.
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009
VATS in lung cancer treatment: for which patients?
Source: International Congress 2014 – An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases
Year: 2014
Association between preoperative pulmonary functions, exercise capacity and surgical outcomes in lung cancer patient
Source: International Congress 2019 – Thoracic surgery
Year: 2019
Surgical treatment of multiple primary lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 136s
Year: 2006
Checkpointinhibition in lung cancer – already standard of care in any line of therapy?
Source: International Congress 2017 – Lung cancer immunotherapy
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept